Acorn Bioventures

United States
Acorn Bioventures invests across stages in small-cap public and private biotechnology companies focused on bringing novel innovative medicines to patients. Our investment flexibility allows us to provide value across the entire spectrum from seed financings, cross-over financings, IPOs, registered direct offerings, PIPEs, open market purchases, etc.
Founded:2017
Firm Location:United States • New York, New York
Acorn Bioventures Team
Photo of Rakesh Ahuja, Analyst at Acorn Bioventures
Rakesh Ahuja
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United States
Investors in BioTech (Series B)
Photo of Anders Hove, Partner at Acorn Bioventures
Anders Hove
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY), Investors in New York
ML
Max Lewin
Acorn Bioventures·Vice President
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY)
Photo of Isaac Manke, Partner at Acorn Bioventures
Isaac Manke
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United States
Investors in BioTech (Series A), Investors in BioTech (Series B)
Photo of Gabriel Schneider, Vice President at Acorn Bioventures
Gabriel Schneider
Acorn Bioventures·Vice President
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United States